These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 24659044

  • 21. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 22. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
    Tong J, Wang Y, Da JP.
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
    [Abstract] [Full Text] [Related]

  • 23. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA, Hussein MRA, Osman MH, Mohamed GA, Hosny G.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3365-3376. PubMed ID: 34711014
    [Abstract] [Full Text] [Related]

  • 24. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan 01; 37(1):35-9. PubMed ID: 18509983
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR, Gucer H.
    Pol J Pathol; 2017 Jan 01; 68(1):1-10. PubMed ID: 28547974
    [Abstract] [Full Text] [Related]

  • 26. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
    Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED.
    PLoS One; 2015 Jan 01; 10(7):e0132939. PubMed ID: 26186733
    [Abstract] [Full Text] [Related]

  • 27. Follicular lesions of the thyroid.
    Mathur A, Olson MT, Zeiger MA.
    Surg Clin North Am; 2014 Jun 01; 94(3):499-513. PubMed ID: 24857573
    [Abstract] [Full Text] [Related]

  • 28. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
    Wiseman SM, Melck A, Masoudi H, Ghaidi F, Goldstein L, Gown A, Jones SJ, Griffith OL.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2811-26. PubMed ID: 18612701
    [Abstract] [Full Text] [Related]

  • 29. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H, Zhang Z, Liu X, Duan H, Xiang T, He Q, Su Z, Wu H, Liang Z.
    J Clin Endocrinol Metab; 2021 Mar 25; 106(4):1011-1021. PubMed ID: 33394038
    [Abstract] [Full Text] [Related]

  • 30. Immunohistochemical Expression of HBME-1 and TROP-2 in Some Follicular-Derived Thyroid Lesions.
    Abu-Seadah SS, Attiah SM, Ali MY, Shams El-Din M, El-Kholy MA.
    Asian Pac J Cancer Prev; 2023 Jul 01; 24(7):2305-2311. PubMed ID: 37505760
    [Abstract] [Full Text] [Related]

  • 31. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.
    Miettinen M, Kärkkäinen P.
    Virchows Arch; 1996 Nov 01; 429(4-5):213-9. PubMed ID: 8972756
    [Abstract] [Full Text] [Related]

  • 32. [HBME-1 and cyclin D1 as diagnostic markers for follicular thyroid carcinoma].
    Moyano L, Franco C, Carreño L, Robinson P, Sánchez G.
    Rev Med Chil; 2004 Mar 01; 132(3):279-84. PubMed ID: 15376563
    [Abstract] [Full Text] [Related]

  • 33. Follicular thyroid carcinoma.
    Sobrinho-Simões M, Eloy C, Magalhães J, Lobo C, Amaro T.
    Mod Pathol; 2011 Apr 01; 24 Suppl 2():S10-8. PubMed ID: 21455197
    [Abstract] [Full Text] [Related]

  • 34. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
    de Micco C, Savchenko V, Giorgi R, Sebag F, Henry JF.
    Br J Cancer; 2008 Feb 26; 98(4):818-23. PubMed ID: 18212751
    [Abstract] [Full Text] [Related]

  • 35. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
    Sanii S, Saffar H, Tabriz HM, Qorbani M, Haghpanah V, Tavangar SM.
    Asian Pac J Cancer Prev; 2012 Feb 26; 13(5):2175-8. PubMed ID: 22901190
    [Abstract] [Full Text] [Related]

  • 36. Can CD10 be used as a diagnostic marker in thyroid pathology?
    Yegen G, Demir MA, Ertan Y, Nalbant OA, Tunçyürek M.
    Virchows Arch; 2009 Jan 26; 454(1):101-5. PubMed ID: 19031085
    [Abstract] [Full Text] [Related]

  • 37. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M, Weynand B, Rahier J, Mourad M, Hamoir M, Marbaix E.
    Diagn Pathol; 2015 Apr 18; 10():32. PubMed ID: 25907675
    [Abstract] [Full Text] [Related]

  • 38. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
    Sadiq Q, Sekhri R, Dibaba DT, Zhao Q, Agarwal S.
    World J Surg Oncol; 2021 May 08; 19(1):143. PubMed ID: 33964951
    [Abstract] [Full Text] [Related]

  • 39. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S, Azhar Sha S, Abdullah Suhaimi SN, Kassim N, Mahasin M, Mohd Saleh MF, Md Isa N.
    Malays J Pathol; 2018 Aug 08; 40(2):111-119. PubMed ID: 30173227
    [Abstract] [Full Text] [Related]

  • 40. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ.
    Int J Surg Pathol; 2004 Apr 08; 12(2):107-15. PubMed ID: 15173915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.